Dexpramipexole improves bioenergetics and outcome in experimental stroke
Sign Up to like & getrecommendations! Published in 2018 at "British Journal of Pharmacology"
DOI: 10.1111/bph.13790
Abstract: Dexpramipexole, a drug recently tested in patients with amyotrophic lateral sclerosis (ALS,) is able to bind F1Fo ATP synthase and increase mitochondrial ATP production. Here, we have investigated its effects on experimental ischaemic brain injury. read more here.
Keywords: outcome experimental; experimental stroke; pharmacology; dexpramipexole improves ... See more keywords